Penrose has assembled an advisory board of some of the most experienced and establish healthcare and business advisors in the world. 

Navdeep Chandel, Ph.D.

Professor of Medicine, Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine

Dr. Chandel is a Professor of Medicine, Biochemistry and Molecular Genetics at Northwestern University Feinberg School of Medicine with over 25 years of experience focused on understanding mitochondria as signaling organelles.

Mircea Ivan, M.D., Ph.D.

Associate Professor of Medicine at the University of Indiana School of Medicine

Dr. Ivan is a microbiologist and immunologist whose research contributed to a Nobel Prize for Medicine or Physiology in 2019. He is a leading researcher in hypoxia, having pioneered the study of noncoding RNAs regulated by oxygen deprivation. He is also focused on combinatorial therapeutic approaches in oncology and tumor metabolism. 

David Rubin, M.D.

Joseph B. Kirsner Professor Chair, Chief of the Section of Gastroenterology, Hepatology and Nutrition and the Co-Director, Digestive Diseases Center at the University of Chicago Medicine

Dr. Rubin has over 30 years’ experience in the gastroenterology field with particular expertise in high-risk cancer syndromes and inflammatory bowel diseases.

Vicki Seyfert-Margolis, Ph.D.

Chief Executive Officer and Founder, MyOwnMed

Dr. Seyfert-Margolis has decades of regulatory and research leadership experience at both the U.S. FDA and NIH, where she oversaw development of agency wide regulatory plans and integrating emerging technologies into research programs. 

Patrick Farmer, Ph.D.

Professor and Chair of the Department of Chemistry and Biochemistry, Baylor University

Dr. Farmer has extensive chemical and biochemical expertise, with research programs on metalloproteins and enzymes redox catalysis, metal-based therapies for melanoma and most recently on enzymes that target flavonols and similar antioxidants.

Bhardwaj Desai, M.D.

Chief Strategic Medical and Clinical Development Consultant of Oncology Innovation, Parexel

Dr. Desai is a hematologist and medical oncologist with three decades of clinical oncology. He is a leader in oncology clinical drug development across all classes of medication and phases of development.

James Stankiewicz, M.D.

Professor of Otolaryngology, Loyola University Medical Center

Dr. Stankiewicz is a renowned physician at the Loyola University Medical Center in Chicago where he has been for over 40 years and started the first Nasal Sinus Center.